(Q37199533)

18 August 2017

Induction effects of ritonavir: implications for drug interactions (English)

1 reference

18 August 2017

1 reference

Michelle M Foisy

1

1 reference

18 August 2017

Erin M Yakiwchuk

series ordinal

2

1 reference

18 August 2017

Christine A Hughes

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

24 June 2008

1 reference

Annals of Pharmacotherapy

18 August 2017

1 reference

18 August 2017

42

1 reference

18 August 2017

7

1 reference

18 August 2017

1048-1059

1 reference

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

18 August 2017

1 reference

Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein?

21 January 2018

1 reference

Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers

21 January 2018

1 reference

Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes

21 January 2018

1 reference

Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein

21 January 2018

1 reference

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

21 January 2018

1 reference

Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line

21 January 2018

1 reference

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

21 January 2018

1 reference

Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers

21 January 2018

1 reference

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

21 January 2018

1 reference

Interactions among drugs for HIV and opportunistic infections

21 January 2018

1 reference

Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir

21 January 2018

1 reference

Drug interactions between antiretroviral drugs and comedicated agents

21 January 2018

1 reference

Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions

21 January 2018

1 reference

Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction.

21 January 2018

1 reference

Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers

21 January 2018

1 reference

Cytochromes P450 and metabolism of xenobiotics

21 January 2018

1 reference

Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers

21 January 2018

1 reference

UDP-glucuronosyltransferases and clinical drug-drug interactions

21 January 2018

1 reference

Glucuronidation enzymes, genes and psychiatry

21 January 2018

1 reference

Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, part I.

21 January 2018

1 reference

Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, Part II.

21 January 2018

1 reference

The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine

21 January 2018

1 reference

Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects

21 January 2018

1 reference

Potential interaction involving warfarin and ritonavir

21 January 2018

1 reference

Interaction between lopinavir/ritonavir and warfarin

21 January 2018

1 reference

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

21 January 2018

1 reference

Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject

21 January 2018

1 reference

Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.

21 January 2018

1 reference

Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir

21 January 2018

1 reference

Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder

21 January 2018

1 reference

Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.

21 January 2018

1 reference

Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir

21 January 2018

1 reference

Differences in pharmacogenetics of nicotine and alcohol metabolism: review and recommendations for future research.

21 January 2018

1 reference

Interactions between antiretrovirals and antineoplastic drug therapy.

21 January 2018

1 reference

Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study

21 January 2018

1 reference

Pharmacogenetics of warfarin elimination and its clinical implications

21 January 2018

1 reference

Severe interaction between ritonavir and acenocoumarol

21 January 2018

1 reference

Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir

21 January 2018

1 reference

The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients

21 January 2018

1 reference

Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir

21 January 2018

1 reference

The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone

21 January 2018

1 reference

Decreased methadone effect after ritonavir initiation

21 January 2018

1 reference

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

21 January 2018

1 reference

Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

21 January 2018

1 reference

In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation

21 January 2018

1 reference

Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers

21 January 2018

1 reference

Pharmacology of Systemic Antifungal Agents

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1K615

1 reference

18 August 2017

1 reference